Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 0.00% is 100% below its 5-year average of 45.11%, near the low end of its 5-year range (0.00%–101.89%).
As of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
DEBT TO ASSETS RATIO
0.00%
DEBT TO ASSETS RATIO AVG TTM
0.00%
DEBT TO ASSETS RATIO AVG 3Y
49.30%
DEBT TO ASSETS RATIO AVG 5Y
45.11%
DEBT TO ASSETS RATIO AVG 10Y
26.18%
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
-100.00%
CURRENT VS 5Y AVG
-100.00%
CURRENT VS 10Y AVG
-100.00%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 810 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Eloxx Pharmaceuticals, Inc.
Market Cap
$50.45M
Debt to Assets Ratio
0.00%
TTM Avg
0.00%
3Y Avg
49.30%
5Y Avg
45.11%
Market Cap
$49.90M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$49.55M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$51.42M
Debt to Assets Ratio
0.06%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Eloxx Pharmaceuticals, Inc. (ELOX) | $50.45M | 0.00% | 0.00% | 49.30% | 45.11% |
| INmune Bio, Inc. (INMB)vs › | $50.51M | 0.05% | N/A | N/A | N/A |
| Celularity Inc. (CELU)vs › | $50.37M | 0.61% | N/A | N/A | N/A |
| Clene Inc. (CLNN)vs › | $50.67M | 0.97% | N/A | N/A | N/A |
| Apollomics, Inc. (APLM)vs › | $50.14M | 0.10% | N/A | N/A | N/A |
| Microbot Medical Inc. (MBOT)vs › | $49.90M | 0.01% | N/A | N/A | N/A |
| Sensus Healthcare, Inc. (SRTS)vs › | $49.55M | 0.01% | N/A | N/A | N/A |
| eXoZymes, Inc. (EXOZ)vs › | $51.42M | 0.14% | N/A | N/A | N/A |
| Rani Therapeutics Holdings, Inc. (RANI)vs › | $51.42M | 0.06% | N/A | N/A | N/A |
| Tenax Therapeutics, Inc. (TENX)vs › | $51.46M | 0.00% | N/A | N/A | N/A |
Debt/Assets
0.0%
Debt/Equity
0.00
Current Ratio
3.74
Interest Coverage
-6.1x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2023-09-30 | 95.30% |
| 2023-06-30 | 101.89% |
| 2023-03-31 | 86.61% |
| 2022-12-31 | 63.36% |
| 2022-09-30 | 49.89% |
| 2022-06-30 | 40.79% |
| 2022-03-31 | 30.73% |
| 2021-12-31 | 29.81% |
| 2021-09-30 | 24.45% |
| 2021-06-30 | 18.47% |
| 2021-03-31 | 52.86% |
| 2020-12-31 | 45.46% |
| 2020-09-30 | 40.35% |
| 2020-06-30 | 36.40% |
| 2020-03-31 | 31.84% |
| 2019-12-31 | 26.74% |
| 2019-09-30 | 22.85% |
| 2019-06-30 | 19.64% |
| 2019-03-31 | 27.24% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-06-30 | 6.97% |
| 2017-03-31 | 4.40% |
| 2016-12-31 | 5.17% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
